Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (FY)Dec 31, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -2.49%5.49B | -6.30%2.6B | 2.93%5.63B | 11.29%2.78B | 22.28%5.47B | 65.28%2.49B | 52.42%4.48B | -2.73%1.51B | -25.31%2.94B | -14.14%1.55B |
| Operating income | -2.49%5.49B | -6.30%2.6B | 2.93%5.63B | 11.29%2.78B | 22.28%5.47B | 65.28%2.49B | 52.42%4.48B | -2.73%1.51B | -25.31%2.94B | -14.14%1.55B |
| Cost of sales | 2.99%-4.81B | 8.57%-2.26B | -0.52%-4.96B | -5.65%-2.47B | -22.79%-4.93B | -48.21%-2.34B | -56.05%-4.02B | -28.16%-1.58B | 6.45%-2.57B | -2.83%-1.23B |
| Operating expenses | 2.99%-4.81B | 8.57%-2.26B | -0.52%-4.96B | -5.65%-2.47B | -22.79%-4.93B | -48.21%-2.34B | -56.05%-4.02B | -28.16%-1.58B | 6.45%-2.57B | -2.83%-1.23B |
| Gross profit | 1.18%684.5M | 12.29%338.59M | 24.87%676.5M | 98.10%301.51M | 17.80%541.77M | 313.85%152.2M | 26.69%459.89M | -122.35%-71.17M | -69.25%363M | -47.61%318.47M |
| Selling expenses | 9.72%-190.04M | 6.76%-74.58M | 15.51%-210.52M | 2.64%-79.99M | -15.74%-249.18M | 26.55%-82.16M | -32.92%-215.29M | -33.88%-111.87M | 8.94%-161.98M | 31.76%-83.56M |
| Administrative expenses | 6.05%-360.03M | -9.87%-143.05M | 9.79%-383.23M | -7.19%-130.2M | -19.31%-424.8M | 29.40%-121.46M | -6.28%-356.06M | 31.66%-172.04M | 38.82%-335.01M | 9.52%-251.75M |
| Research and development expenses | -8.72%-163.57M | -31.84%-76.75M | -33.84%-150.46M | -57.25%-58.21M | 9.04%-112.42M | 37.41%-37.02M | 15.13%-123.59M | ---59.14M | ---145.61M | ---- |
| Impairment and provision | -23.67%94.91M | -26.85%8.84M | 755.04%124.35M | 146.44%12.08M | 93.66%-18.98M | 73.51%-26.01M | 17.60%-299.19M | -41.51%-98.19M | -35.61%-363.1M | -5.73%-69.39M |
| -Other impairment is provision | -23.67%94.91M | -26.85%8.84M | 755.04%124.35M | 146.44%12.08M | 93.66%-18.98M | 73.51%-26.01M | 17.60%-299.19M | -41.51%-98.19M | -35.61%-363.1M | -5.73%-69.39M |
| Special items of operating profit | 16.46%106.6M | -21.00%28.26M | 43.61%91.53M | -61.06%35.78M | -36.91%63.74M | -4.33%91.89M | 211.06%101.03M | 34.42%96.04M | -19.36%32.48M | 124.01%71.45M |
| Operating profit | 16.32%172.36M | 0.42%81.31M | 174.14%148.18M | 458.86%80.97M | 53.86%-199.86M | 94.58%-22.56M | 29.01%-433.2M | -2,718.06%-416.37M | -368.32%-610.21M | -108.52%-14.78M |
| Financing income | 12.09%27.76M | 39.27%15.5M | -35.29%24.77M | -10.78%11.13M | -43.32%38.28M | -24.13%12.48M | -29.42%67.53M | -70.08%16.44M | -0.49%95.68M | 236.92%54.95M |
| Financing cost | 22.19%-120.69M | 29.38%-56.48M | 27.48%-155.11M | 48.63%-79.98M | 16.71%-213.88M | 4.16%-155.69M | -12.45%-256.78M | -48.26%-162.45M | -2.62%-228.35M | 13.21%-109.57M |
| Share of profits of associates | ---- | -842.02%-2.79M | ---- | 127.43%376K | -1,424.84%-35.54M | -18.50%-1.37M | 5.24%-2.33M | 49.10%-1.16M | 83.56%-2.46M | 80.23%-2.27M |
| Share of profit from joint venture company | -139.70%-8.73M | ---- | --21.98M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Earning before tax | 77.57%70.71M | 200.40%37.54M | 109.69%39.82M | 107.48%12.5M | 34.22%-411.01M | 70.34%-167.15M | 16.18%-624.78M | -686.25%-563.54M | -965.77%-745.34M | -237.72%-71.67M |
| Tax | 10.48%-31.41M | 93.40%-997K | -324.83%-35.09M | -1,456.54%-15.11M | -2,417.99%-8.26M | -106.54%-971K | -102.89%-328K | 182.00%14.86M | 143.71%11.34M | 140.09%5.27M |
| After-tax profit from continuing operations | 729.86%39.3M | 1,497.06%36.55M | 101.13%4.74M | 98.44%-2.62M | 32.93%-419.27M | 69.36%-168.12M | 14.84%-625.11M | -726.25%-548.68M | -1,320.49%-734M | -270.70%-66.41M |
| Earning after tax | 729.86%39.3M | 1,497.06%36.55M | 101.13%4.74M | 98.44%-2.62M | 32.93%-419.27M | 69.36%-168.12M | 14.84%-625.11M | -726.25%-548.68M | -1,320.49%-734M | -270.70%-66.41M |
| Minority profit | 134.58%982K | 89.12%-548K | 91.31%-2.84M | 63.85%-5.04M | -451.00%-32.67M | 44.95%-13.93M | 155.37%9.31M | -485.67%-25.3M | -260.40%-16.81M | -15.27%6.56M |
| Profit attributable to shareholders | 405.81%38.32M | 1,433.48%37.1M | 101.96%7.58M | 101.57%2.42M | 39.06%-386.6M | 70.54%-154.19M | 11.54%-634.42M | -617.30%-523.38M | -1,544.20%-717.19M | -334.16%-72.97M |
| Basic earnings per share | 437.50%0.0043 | 1,266.67%0.0041 | 101.44%0.0008 | 101.03%0.0003 | 53.76%-0.0554 | 70.55%-0.0291 | 11.52%-0.1198 | -615.94%-0.0988 | -1,540.43%-0.1354 | -333.90%-0.0138 |
| Diluted earnings per share | 437.50%0.0043 | 1,266.67%0.0041 | 101.44%0.0008 | 101.03%0.0003 | 53.76%-0.0554 | 70.55%-0.0291 | 11.52%-0.1198 | -615.94%-0.0988 | -1,540.43%-0.1354 | -333.90%-0.0138 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- | -- |
| Auditor | Deloitte Touche Tohmatsu会计师事务所 | -- | Deloitte Touche Tohmatsu会计师事务所 | -- | Deloitte Touche Tohmatsu会计师事务所 | -- | Deloitte Touche Tohmatsu会计师事务所 | -- | PwC | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.